home All News open_in_new Full Article

Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak

Shareholders stand to receive a significant and attractive cash premium, as the purchase price of US$3.01, with a contingent value right for potential additional aggregate payments of up to US$1.19 per share, represents a compelling premium of 216% to the closing price on the Nasdaq on April 10, 2025, the date prior to the announcement […]


today 31 h. ago attach_file Other

attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Other
attach_file Other
attach_file Economics
attach_file Other
attach_file Culture
attach_file Sport
attach_file Culture
attach_file Politics
attach_file Other
attach_file Politics
attach_file Events
attach_file Economics
attach_file Other
attach_file Other
attach_file Politics


ID: 48215592
Add Watch Country

arrow_drop_down